{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:08:12Z","timestamp":1778526492400,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Latin American Brain Health Institute","award":["BL-SRGP2020-05"],"award-info":[{"award-number":["BL-SRGP2020-05"]}]},{"DOI":"10.13039\/100015442","name":"Global Brain Health Institute","doi-asserted-by":"publisher","award":["212322"],"award-info":[{"award-number":["212322"]}],"id":[{"id":"10.13039\/100015442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015442","name":"Global Brain Health Institute","doi-asserted-by":"publisher","award":["13833"],"award-info":[{"award-number":["13833"]}],"id":[{"id":"10.13039\/100015442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.vhri.2025.101148","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:09:13Z","timestamp":1750158553000},"page":"101148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Valuation of the Alzheimer\u2019s Disease 5 Dimensions Instrument: A Discrete Choice Experiment With Life Duration in Chile"],"prefix":"10.1016","volume":"50","author":[{"given":"Daniel A.","family":"Araya-R\u00edos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim-Huong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy A.","family":"Comans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Tr\u00e9pel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2025.101148_bib1","author":"Long"},{"issue":"10248","key":"10.1016\/j.vhri.2025.101148_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vhri.2025.101148_bib3","series-title":"Global Action Plan on the Public Health Response to Dementia 2017-2025","year":"2017"},{"issue":"7","key":"10.1016\/j.vhri.2025.101148_bib5","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/alz.12901","article-title":"The worldwide costs of dementia in 2019","volume":"19","author":"Wimo","year":"2023","journal-title":"Alzheimers Dem"},{"issue":"6","key":"10.1016\/j.vhri.2025.101148_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14737167.2020.1822738","article-title":"Challenges in demonstrating the value of disease-modifying therapies for Alzheimer\u2019s disease","volume":"20","author":"Gustavsson","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.vhri.2025.101148_bib7","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"4","key":"10.1016\/j.vhri.2025.101148_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1524-4733.2008.00489.x","article-title":"Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report","volume":"12","author":"Drummond","year":"2009","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2025.101148_bib9","article-title":"Health technology assessment in middle-income countries: recommendations for a balanced assessment system","volume":"2","author":"Dank\u00f3","year":"2014","journal-title":"J Mark Access Health Policy"},{"issue":"4","key":"10.1016\/j.vhri.2025.101148_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jval.2017.09.005","article-title":"Utility-based instruments for people with dementia: a systematic review and meta-regression analysis","volume":"21","author":"Li","year":"2018","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2025.101148_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12955-017-0585-0","article-title":"Developing a dementia-specific health state classification system for a new preference-based instrument AD-5D","volume":"15","author":"Nguyen","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"10.1016\/j.vhri.2025.101148_bib12","doi-asserted-by":"crossref","first-page":"v","DOI":"10.3310\/hta17050","article-title":"Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation","volume":"17","author":"Mulhern","year":"2013","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.vhri.2025.101148_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jval.2015.07.011","article-title":"A simple and practical index to measure dementia-related quality of life","volume":"19","author":"Arons","year":"2016","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.vhri.2025.101148_bib14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s40273-020-00913-7","article-title":"Valuing the AD-5D dementia utility instrument: an estimation of a general population tariff","volume":"38","author":"Comans","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vhri.2025.101148_bib15","first-page":"21","article-title":"Quality of life in Alzheimer\u2019s disease: patient and caregiver reports","volume":"5","author":"Logsdon","year":"1999","journal-title":"J Ment Health Aging"},{"issue":"3","key":"10.1016\/j.vhri.2025.101148_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00006842-200205000-00016","article-title":"Assessing quality of life in older adults with cognitive impairment","volume":"64","author":"Logsdon","year":"2002","journal-title":"Psychosom Med"},{"issue":"1","key":"10.1016\/j.vhri.2025.101148_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13607863.2014.915923","article-title":"Quality of life in dementia: a systematically conducted narrative review of dementia-specific measurement scales","volume":"19","author":"Bowling","year":"2014","journal-title":"Aging Ment Health"},{"issue":"6","key":"10.1016\/j.vhri.2025.101148_bib18","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0277-9536(01)00066-1","article-title":"To what extent can we explain time trade-off values from other information about respondents?","volume":"54","author":"Dolan","year":"2002","journal-title":"Soc Sci Med"},{"issue":"5","key":"10.1016\/j.vhri.2025.101148_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40271-022-00572-0","article-title":"Determinants of health preferences using data from the Egyptian EQ-5D-5L Valuation Study","volume":"15","author":"Al Shabasy","year":"2022","journal-title":"Patient Centered Outcomes Res"},{"issue":"5","key":"10.1016\/j.vhri.2025.101148_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jclinepi.2006.08.008","article-title":"Racial\/ethnic differences in preferences for the EQ-5D health states: results from the US valuation study","volume":"60","author":"Shaw","year":"2007","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.vhri.2025.101148_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/0272989X19841587","article-title":"Cultural values: can they explain differences in health utilities between countries?","volume":"39","author":"Roudijk","year":"2019","journal-title":"Med Decis Mak"},{"issue":"3","key":"10.1016\/j.vhri.2025.101148_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00005650-200503000-00004","article-title":"Valuations of EQ-5D health states: are the United States and United Kingdom different?","volume":"43","author":"Johnson","year":"2005","journal-title":"Med Care"},{"issue":"6","key":"10.1016\/j.vhri.2025.101148_bib23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jval.2013.05.006","article-title":"Health state valuation in low- and middle-income countries: a systematic review of the literature","volume":"16","author":"Kularatna","year":"2013","journal-title":"Value Health"},{"issue":"100","key":"10.1016\/j.vhri.2025.101148_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.socscimed.2014.05.026","article-title":"Testing a discrete choice experiment including duration to value health states for large descriptive systems: addressing design and sampling issues","volume":"114","author":"Bansback","year":"2014","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.vhri.2025.101148_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhealeco.2011.11.004","article-title":"Using a discrete choice experiment to estimate health state utility values","volume":"31","author":"Bansback","year":"2012","journal-title":"J Health Econ"},{"issue":"1","key":"10.1016\/j.vhri.2025.101148_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1536867X1401400104","article-title":"Calibrating survey data using iterative proportional fitting (raking)","volume":"14","author":"Kolenikov","year":"2014","journal-title":"STATA J"},{"key":"10.1016\/j.vhri.2025.101148_bib28","series-title":"Estimaciones y Proyecciones de Poblaci\u00f3n 1992-2050","year":"2023"},{"key":"10.1016\/j.vhri.2025.101148_bib29","series-title":"Encuesta de caracterizaci\u00f3n socioecon\u00f3mica nacional (CASEN) 2022","year":"2022"},{"key":"10.1016\/j.vhri.2025.101148_bib30","series-title":"Discrete Choice Methods With Simulation","author":"Train","year":"2009"},{"key":"10.1016\/j.vhri.2025.101148_bib31","series-title":"The Economics of Non-Market Goods and Resources. Netherlands Antilles","article-title":"Using discrete choice experiments to value health and health care","author":"Ryan","year":"2007"},{"key":"10.1016\/j.vhri.2025.101148_bib32","series-title":"Stated Choice Methods: Analysis and Applications","author":"Louviere","year":"2000"},{"key":"10.1016\/j.vhri.2025.101148_bib33","author":"Hess"},{"issue":"1","key":"10.1016\/j.vhri.2025.101148_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1145\/151271.151279","article-title":"Algorithm 717: Subroutines for maximum likelihood and quasi-likelihood estimation of parameters in nonlinear regression models","volume":"19","author":"Bunch","year":"1993","journal-title":"ACM Trans Math Softw (TOMS)"},{"issue":"8","key":"10.1016\/j.vhri.2025.101148_bib35","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jval.2011.09.002","article-title":"Social valuation of EQ-5D health states: the Chilean case","volume":"14","author":"Zarate","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2025.101148_bib36","series-title":"Censo de Poblaci\u00f3n y Vivienda 2017","year":"2017"},{"issue":"4","key":"10.1016\/j.vhri.2025.101148_bib37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","article-title":"Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force","volume":"19","author":"Hauber","year":"2016","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2025.101148_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","article-title":"Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force","volume":"16","author":"Johnson","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2025.101148_bib39","series-title":"Measuring and Valuing Health Benefits for Economic Evaluation","author":"Brazier","year":"2017"},{"issue":"11","key":"10.1016\/j.vhri.2025.101148_bib40","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s40273-018-0690-x","article-title":"Utility values for health states in Ireland: a value set for the EQ-5D-5L","volume":"36","author":"Hobbins","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.vhri.2025.101148_bib41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40273-018-0615-8","article-title":"German value set for the EQ-5D-5L","volume":"36","author":"Ludwig","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.vhri.2025.101148_bib42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.mlr.0000252166.76255.68","article-title":"The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets","volume":"45","author":"Lamers","year":"2007","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.vhri.2025.101148_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0272989X9401400102","article-title":"Measuring preferences for health states worse than death","volume":"14","author":"Patrick","year":"1994","journal-title":"Med Decis Mak"},{"issue":"3","key":"10.1016\/j.vhri.2025.101148_bib44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/hec.1596","article-title":"A uniform time trade off method for states better and worse than dead: feasibility study of the \u2018lead time\u2019approach","volume":"20","author":"Devlin","year":"2011","journal-title":"Health Econ"},{"issue":"4","key":"10.1016\/j.vhri.2025.101148_bib45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/hec.2804","article-title":"Lead time TTO: leading to better health state valuations?","volume":"22","author":"Attema","year":"2013","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.vhri.2025.101148_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40273-018-0714-6","article-title":"One method, many methodological choices: a structured review of discrete-choice experiments for health state valuation","volume":"37","author":"Mulhern","year":"2019","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1016\/j.vhri.2025.101148_bib47","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.socscimed.2006.12.007","article-title":"Several methods to investigate relative attribute impact in stated preference experiments","volume":"64","author":"Lancsar","year":"2007","journal-title":"Soc Sci Med"},{"issue":"10","key":"10.1016\/j.vhri.2025.101148_bib48","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jval.2020.06.010","article-title":"Do discrete choice experiments approaches perform better than time trade-off in eliciting health state utilities? Evidence from SF-6Dv2 in china","volume":"23","author":"Xie","year":"2020","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2025.101148_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.vhri.2019.10.002","article-title":"Implementing health technology assessments in Latin America: looking at the past, mirroring the future. A perspective from the ISPOR health technology assessment roundtable in Latin America","volume":"23","author":"Gilardino","year":"2020","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.vhri.2025.101148_bib50","series-title":"Estudio D\u00e9cima Encuesta sobre acceso, usos y usuarions de Internet en Chile","year":"2023"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:11:46Z","timestamp":1778523106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":48,"alternative-id":["S2212109925000731"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101148","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valuation of the Alzheimer\u2019s Disease 5 Dimensions Instrument: A Discrete Choice Experiment With Life Duration in Chile","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101148"}}